HomeBNTX • NASDAQ
add
BioNTech SE - ADR
$102.70
After Hours:(0.0097%)-0.0100
$102.69
Closed: Nov 26, 4:05:54 PM GMT-5 · USD · NASDAQ · Disclaimer
Previous close
$99.71
Day range
$98.72 - $102.90
Year range
$81.20 - $129.27
Market cap
23.91B USD
Avg Volume
810.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.52B | 22.02% |
Operating expense | 1.40B | 34.32% |
Net income | -28.70M | -114.49% |
Net profit margin | -1.89 | -111.88% |
Earnings per share | -0.12 | -114.81% |
EBITDA | 91.20M | 39.66% |
Effective tax rate | 216.19% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.53B | -13.06% |
Total assets | 21.34B | -4.73% |
Total liabilities | 2.86B | -12.87% |
Total equity | 18.48B | — |
Shares outstanding | 240.46M | — |
Price to book | 1.30 | — |
Return on assets | -0.38% | — |
Return on capital | -0.44% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -28.70M | -114.49% |
Cash from operations | 780.70M | 222.19% |
Cash from investing | -925.30M | -551.16% |
Cash from financing | -11.50M | -45.57% |
Net change in cash | -176.60M | 76.52% |
Free cash flow | 1.05B | 253.59% |
About
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
CEO
Founded
2008
Website
Employees
6,772
